Jeff Frelick - 31 Aug 2023 Form 4 Insider Report for Bone Biologics Corp (BBLG)

Role
Chief Executive Officer
Signature
/s/ Jeffrey Frelick
Issuer symbol
BBLG
Transactions as of
31 Aug 2023
Net transactions value
+$5,020
Form type
4
Filing time
05 Sep 2023, 18:05:23 UTC
Previous filing
08 Mar 2023
Next filing
12 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBLG Common Stock Purchase $5,020 +7,600 +7308% $0.6605 7,704 31 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 104 shares of vested restricted stock that were inadvertently reported in Table II at the time of grant.